Abstract
In this decade, genetic toxicology has emerged as an interdisciplinary science that aims to understand the mechanisms of action of agents that induce mutations and to appraise the human risks posed by exposure to such agents. Our research into chemical mutagenesis has shown us that some chemical types in themselves or after metabolic activation are capable of altering the informational content encoded in the base sequence of DNA. It now becomes understandable that adverse health effects in man such as carcinogenesis, mutagenesis, and teratogenesis may result from overexposure to such chemicals that alter genetic material. Thus it behooves us as scientists to use the many mutagenicity testing methods that have been developed—and are being developed—to study these genotoxic substances.
This manuscript has been supported by EPA Grant R804621020 (Project Officer: Dr. J.F. Stara).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ames, B.N., Whitfield, H.J.,Jr. (1966): Frameshift mutagenesis in Salmonella. Cold Spring Harbor Symp. Quant. Biol. 37: 221–225.
Ames, B.N., Gurney, E.G., Miller, J.A., Bartsch, H. (1972a): Carcinogens as frameshift mutagens: metabolites and derivatives of 2-acetylaminofluorene and other aromatic amine carcinogens. Proc. Natl. Acad. Sci. USA 69: 3128–3132.
Ames, B.N., Sims, P., Grover, P.L. (1972b): Epoxides of carcinogenic polycyclic hydrocarbons are frameshift mutagens. Science 776: 47–49.
Ames, B.N., McCann, J., Yamasaki, E. (1975): Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutat. Res. 57: 347–363.
Arnold, D.L., Charbonneau, S.M., Moodie, C.A., Munro, I.C. (1977): Long-term toxicity study with ortho-toluenesulfonamide and saccharin. Sixteenth Annual Meeting of the Society of Toxicology, Toronto, Abstract 78.
Ashby, J., Styles, J.A. (1978): Factors influencing mutagenic potency in vitro. Nature (Lond.) 274: 20–22.
Badr, F.M., Badr, R.S. (1974): Studies on the mutagenic effect of contraceptive drugs. I. Introduction of dominant lethal mutations in female mice. Mutat. Res. 26: 529–534.
Batzinger, R.P., Bueding, E., Reddy, B.S., Weisburger, J.H. (1978): Formation of a mutagenic drug metabolite by intestinal microorganisms. Cancer Res. 38: 608–612.
Benedict, W.F., Banerjee, A., Gardner, A., Jones, P. A. (1977a): Induction of morphological transformation in mouse C3H/10T1/2 clone 8 cells and chromosomal damage in hamster A(T1)C1-3 cells by cancer chemotherapeutic agents. Cancer Res. 57: 2202–2208.
Benedict, W.F., Baker, M.S., Haroun, L., Choi, E., Ames, B.N. (1977b): Mutagenicity of cancer chemotherapeutic agents in the Salmonella I microsome test. Cancer Res. 57: 2209–2213.
Benedict, W.F., Banerjee, A., Venkatesan, N. (1978): Cyclophosphamide-induced oncogenic transformation, chromosomal breakage, and sister chromatid exchange following microsomal activation. Cancer Res. 38: 2922–2924.
Bimboes, D., Greim, H. (1976): Human lymphocytes as target cells in a metabolizing test system in vitro for detecting potential mutagens. Mutat. Res. 55: 155–160.
Bloom, A.D., Nakagoma, Y., Awa, A.A., Neriiski, S. (1970): Chromosome aberrations and malignant disease among A-bomb survivors. Am. J. Publ. Health 60: 641–644.
Bochkov, N.B., Sram, R.J., Kuleshov, N.P., Zhurkov, V.S. (1976): System for the evaluation of the risk from chemical mutagens for man: basic principles and practical recommendations. Mutat. Res. 55: 191–202.
Bora, K.C. (1976): A hierarchical approach to mutagenicity testing and regulatory control of environmental chemicals. Mutat. Res. 41: 73–82.
Brenner, S., Barnett, L., Crick, F.H.C., Orgel, A. (1961): The theory of mutagenesis. J. Mol. Biol. 5: 121–124.
Bresnick, E. (1976): Activation and inactivation of polycyclic hydrocarbons and their interaction with macromolecular components. In: F. J. de Serres, J.R. Fouts, J.R. Bend, and R.M. Philpot (eds.), In Vitro Metabolic Activation in Mutagenesis Testing. Amsterdam: Elsevier/North Holland Biomedical Press, pp. 91–104.
Bridges, B.A. (1973): Some general principles of mutagenicity screening and a possible framework for testing procedures. Environ. Health Perspect. 6: 221–227.
Bridges, B.A. (1974): The three-tier approach to mutagenicity screening and the concept of radiation-equivalent dose. Mutat. Res. 26: 335–340.
Bridges, B.A. (1976): Use of a three-tier pro-tocol for evaluation of long-term toxic hazards, particularly mutagenicity and carcinogenicity. In: R. Montesano, H. Bartsch, and L. Tomatis (eds.), Screening Tests in Chemical Carcinogenesis (IARC Scientific Publications No. 12 ), Lyon, International Agency for Research on Cancer, pp. 549–568.
Bridges, J.W., Fry, J.R. (1978): Mammalian short-term tests for carcinogens. In: A.D. Dayan and R.W. Brimblecombe (eds.), Carcinogenicity Testing: Principles and Problems. Baltimore: University Park Press, pp. 29–52.
Brusick, D.J. (1977): In vitro mutagenesis assays as predictors of chemical carcinogenesis in mammals. Clin. Toxicol. 70:79–109.
Bryan, J. (1972): Definition of three classes of binding sites in isolated microtubule crystals. Biochemistry 11: 2611–2616.
Casey, T.P. (1968): The development of lymphomas in mice with autoimmune disorders treated with azathioprine. Blood 31: 396–399.
Clark, J.M. (1975): The mutagenicity of azathioprine in mice, Drosophila melanogaster and Neurospora crassa. Mutat. Res. 25: 87-99.
Cleaver, J.E., Bootsma, D. (1975): Xeroderma pigmentosum: biochemical and genetic characteristics. Ann. Rev. Genet. 9: 19–38.
Cohen, M.M., Shaw, M.W., Craig, A.P. (1963): The effects of streptonigrin on cultured human leukocytes. Proc. Natl. Acad. Sci. USA 5016–24.
Committee 17 of the Environmental Mutagen Society (1975): Environmental mutagenic hazards. Science 187: 503–514.
Connor, T.H., Stoeckel, M., Evrard, J., Legator, M.S. (1977): The contribution of metronidazole and two metabolites to the mutagenic activity detected in the urine of treated humans and mice. Cancer Res. 37: 629–633.
Countryman, P.I., Heddle, J.A., Crawford, E. (1977): The repair of X-ray-induced chromosomal damage in trisomy 21 and normal diploid lymphocytes. Cancer Res. 37: 52–58.
Dean, BJ. (1976): A predictive testing scheme for carcinogenicity and mutagenicity of industrial chemicals. Mutat. Res. 41: 83–88.
Dean, B.J., Hodson-Walker, G. (1979): An in vitro chromosome assay using cultured ratliver cells. Mutat. Res. 64: 329–337.
de Serres, F.J. (1974): Report of discussion group no. 12: mutagenic assessment. In: L. Goldberg (ed.), Carcinogenesis Testing of Chemicals. Cleveland, Ohio: CRC Press, pp. 101–107.
de Serres, F.J., Ehling, U., Kihlman, B., Kilbey, B.J., Loprieno, N., Marquardt, H., Ramel, C., Zetterberg, G. (1973): Report of group 5: genetic tests for evaluating environmental mutagens. In: C. Ramel (ed.), Evaluation of Genetic Risks of Environmental Chemicals, Ambio Special Report No. 3, pp. 23–27.
Dickens, F., Jones, H.E.H. (1963): Further studies on the carcinogenic and growth inhibitory activity of lactones and related substances. Br. J. Cancer 77: 100–108.
Dickens, F., Jones, H.E.H. (1965): Further studies on carcinogenesis by lactones and related substances in the rat and mouse. Br. J. Cancer 19: 392–403.
Doell, R.G., St. Cyr, C. de V., Grabar, P. (1967): Immune reactivity prior to development of thymic lymphoma in C57BL mice. Int. J. Cancer 2: 103–108.
Draser, B.S., Hill, M.J. (1974): Human Intestinal Flora. New York: Academic Press.
Draser, B.S., Renwick, A.G., Williams, R.T. (1972): The role of the gut flora in the metabolism of cyclamate. Biochem. J. 734: 881–890.
Duca-Marinescu, D., Negoescu, I. (1972): The mutagenic effects of thyroxin. Rev. Roum. Endocrinol. 70: 149–152.
Ehling, U.H. (1974): Differential spermatogenic response of mice to the induction of mutations by antineoplastic drugs. Mutat. Res. 26: 285–295.
Ellis, J.H., Jr, Ray, V.A., Holden, H.E. (1974): Comparative studies of 6-chloropurine in host-mediated and in vitro bacterial assays. Mutat. Res. 26: 455.
Ezdinli, E.Z., Sokal, J.E., Crosswhite, L., Sandberg, A.A. (1970): Philadelphia-chromosomepositive and -negative chronic myelocytic leukemia. Ann. Intern. Med. 72: 175–182.
Feiton, J.S., Nebert, D.W. (1975): Mutagenesis of certain activated carcinogens in vitro associated with genetically mediated increases in monooxygenase activity and cytochrome Px-450. J. Biol. Chem. 250: 6769–6778.
Fishbein, L., Flamm, W.G., Falk, H.L. (1970): Chemical Mutagens, New York: Academic Press, p. 90.
Flamm, W.G. (1974): A tier system approach to mutagen testing. Mutat. Res. 26: 329–333.
Forni, A., Capellini, A., Pacifico, E., Vigiliani, E.C. (1971): Chromosome changes and their evolution in subjects with past exposure to benzene. Arch. Environ. Health 22: 373–378.
Franz, J. (1970): Chromosomal aberrations induced by antimetabolites. In: F. Vogel and G. Röhrborn (eds.), Chemical Mutagenesis in Mammals and Man. New York: SpringerVerlag, pp. 342–349.
Gale, E.F., Candliffe, E., Reynolds, P.E., Richmond, M.H., Waring, M.J. (1972): The Molecular Basis of Antibiotic Action. New York: John Wiley and Sons, p. 174.
Gebhart, E. (1970): The treatment of human chromosomes in vitro: results. In: F. Vogel and G. Röhrborn (eds.), Chemical Mutagenesis in Mammals and Man. New York: Springer-Verlag, pp. 367–382.
Generoso, W.M., Preston, R.J., Brewen, J.G. (1975): 6-Mercaptopurine, an inducer of cytogenetic and dominant-lethal effects in premeiotic and early meiotic germ cells of male mice. Mutat. Res. 25: 437–447.
Goldberg, I.H., Friedman, P.A. (1971): Antibiotics and nucleic acids. Ann. Rev. Biochem. 40: 775–810.
Grisham, L.M., Wilson L., Bensch, K.G. (1973): Antimitotic action of griseofulvin does not involve disruption of microtubules. Nature (Lond.) 244: 294–296.
Grover, S., Fischer, P. (1971): Cytogenetic studies in Sprague-Dawley rats during the administration of a carcinogenic nitroso compound—diethylnitrosamine. Europ. J. Cancer 7: 77–82.
Hampton, A., Paterson, A.R.P. (1966): Conversion of 6-chloropurine to its ribonucleotide by ascites tumor cells. Biochim. Biophys. Acta 114: 185–187.
Hannan, M.A., Hurley, L.H., Gairola, C. (1978): Mutagenic and recombinogenic effects of the antitumor antibiotic anthramycin. Cancer Res. 38: 2195–2199.
Harnden, D.G., Taylor, A.M.R. (1979): Chromosomes and neoplasia. Adv. Human Genet. 9: 1–70.
Harnden, D.G., Maclean, N., Langlands, A.O. (1971): Carcinoma of the breast and Klinefelter syndrome. J. Med. Genet. 8: 460–461.
Higurashi, M., Conen, P.E. (1973): In vitro chromosomal radiosensitivity in “chromosomal breakage syndromes.” Cancer 32:380–383.
Hite, M., Pecharo, M., Smith, I., Thornton, S. (1980): The effect of benzene in the micronucleus test. Mutat. Res. 77: 149–155.
Holden, H.E., Ray, V.A., Florio, J., Wahrenburg, M.G. (1974): In vivo and in vitro cytogenetic studies with 6-chloropurine. Mutat. Res. 26:455–456.
Holmes, A.J., Eisenstark, A. (1968): The mutagenic effect of thymine-starvation on Salmonella typhimurium. Mutat. Res. 5: 15–21.
Horwitz, S.B. (1975): Anthramycin. In: A.C. Sartorelli and D.G. Johns (eds.), Handbook of Experimental Pharmacology, Vol. 38, Part 2. New York: Springer-Verlag, pp. 642–648.
Hsu, T.C., Collie, C.J., Lusby, A.F., Johnston, D.A. (1977): Cytogenetic assays of chemical clastogens using mammalian cells in culture. Mutat. Res. 45: 233–247.
Huberman, E., Heidelberger, C. (1972): The mutagenicity to mammalian cells of pyrimidine nucleoside analogs. Mutat. Res. 130–132.
IARC (1975-1978): IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. Vols. 10–13, 15, 16, Lyon, International Agency for Research on Cancer.
Infante, P.F., Wagoner, J.K., Waxweiler, R.J. (1976): Carcinogenic, mutagenic and teratogenic risks associated with vinyl chloride. Mutat. Res. 41: 131–142.
Ishidate, M., Jr., Odashima, S. (1977): Chromosome tests with 134 compounds on Chinese hamster cells in vitro—a screening for chemical carcinogens. Mutat. Res. 48: 337–354.
Janion, C. (1978): The efficiency and extent of mutagenic activity of some new mutagens of base-analogue type. Mutat. Res. 56: 225–234.
Jones, J.B., Young, J.M. (1968): Carcinogenicity of lactones. III. The reactions of unsaturated y-lactones with L-cysteine. J. Med. Chem. 11: 1176–1182.
Jones, P.A., Benedict, W.F., Baker, M.S., Mondal, S., Rapp, U., Heidelberger, C. (1976): Oncogenic transformation of C3H/10T1/2 clone 8 mouse embryo cells by halogenated pyrimidine nucleosides. Cancer Res. 36: 101–107.
Knudson, A.G., Jr. (1977): Genetics and etiology of human cancer. Adv. Hum. Genet. 8: 1–66.
Kondo, S., Ichikawa, H., Iwo, K., Kato, T. (1970): Base-change mutagenesis and prophage induction in strains of Escherichia coli with different DNA repair capacities. Genetics 66: 187–217.
Kouri, R.E., Kurtz, S.A., Price, P.J., Benedict, W.F. (1975): l-/3-D-Arabinofuranosylcytosine-induced malignant transformation of hamster and rat cells in culture. Cancer Res. 35: 2413–2419.
Kremer, W.B., Laszilo, J. (1975): Streptonigrin. In: A.C. Sartorelli (ed.), Handbook of Experimental Pharmacology, Vol. 38, Part 2. New York: Springer-Verlag, pp. 633–641.
Kusyk, C.J., Hsu, T.C. (1976): Mitotic anomalies induced by three inhalation halogenated anesthetics. Environ. Res. 12: 366–370.
Laerum, O.D., Iversen, O.H. (1972): Reticuloses and epidermal tumors in hairless mice after topical skin applications of cantharidin and asiaticoside. Cancer Res. 32: 1463–1469.
Lamb, D. (1967): Correlation of chromosome counts with histological appearances and prognosis in transitional-cell carcinoma of bladder. Br. Med. J. 1: 263–211.
Lawley, P.D., Orr, D.J., Shah, S.A., Farmer, P.B., Jarman, M. (1973): Reaction products of N-methyl-N-nitrosourea and deoxyribonucleic acid containing thymidine residues. Biochem. J. 135: 193–201.
Leclercq, G., Hulin, N., Heuson, J.C. (1973): Interaction of activated estradiol-receptor complex and chromatin in isolated uterine nuclei. Europ. J. Cancer 9: 681–685.
Legator, M.S., Zimmering, S. (1975): Integration of mammalian, microbial, and Drosophila procedures for evaluating chemical mutagens. Mutat. Res. 29: 181–188.
Lerman, L.S. (1964): Acridine mutagens and DNA structure. J. Cell. Comp. Physiol. 64 (Suppl. 1): 1–18.
Levine, A.F., Fink, L.M., Weinstein, I.B., Grunberger, D. (1974): Effect of N-2acetylaminofluorene modification on the conformation of nucleic acids. Cancer Res. 34: 319–327.
Loeb, L.A., Sirover, M.A., Agarwal, S.S. (1978): Infidelity of DNA synthesis as related to mutagenesis and carcinogenesis. Adv. Exp. Med. Biol. 91: 103–115.
Mailing, H.V. (1971): Dimethylnitrosamine: formation of mutagenic compounds by interaction with mouse liver microsomes. Mutat. Res. 13: 425–429.
Manolov, G., Manolova, Y. (1972): Marker band in one chromosome 14 from Burkitt lymphomas. Nature (Lond.) 237: 33–34.
Martz, F., Straw, J.A. (1977): The in vitro metabolism of 1 -(o-chlorophenyl)-1 -(pchlorophenyl)-2,2-dichloroethane (o-pDDD) by dog adrenal mitochondria and metabolite covalent binding to mitochondrial macromolecules. Drug. Metab. Disp. 5: 482–486.
Matsuoka, A., Hayashi, M., Ishidate, M., Jr. (1979): Chromosomal aberration tests on 29 chemicals combined with S-9 mix in vitro. Mutat. Res. 66: 277–290.
Mayer, V.W., Flamm, W.G. (1975): Legislative and technical aspects of mutagenicity testing. Mutat. Res. 29: 295–300.
McCann, J., Spingarn, N.E., Kobori, J., Ames, B.N. (1975): Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids. Proc. Natl. Acad. Sci. USA 72: 979–983.
Miller, E.C., Miller, J.A. (1971): The mutagenicity of chemical carcinogens: correlations, problems, and interpretations. In: A. Hollaender (ed.), Chemical Mutagens: Principles and Methods for Their Detection. New York: Plenum Press, pp. 83–119.
Miller, R.W. (1970): Neoplasia and Down’s syndrome. Ann. N.Y. Acad. Sci. 171: 637–644.
Mulvihill, J.J. (1975): Congenital and genetic diseases. In: J.F. Fraumeni, Jr. (ed.), Persons at High Risk of Cancer. New York: Academic Press, pp. 3–37.
Musilova, J., Michalova, K., Urban, J. (1979): Sister-chromatid exchanges and chromosomal breakage in patients treated with cytostatics. Mutat. Res. 67: 289–294.
National Cancer Institute (1978): Bioassay of /3-TGdR for Possible Carcinogenicity, Carcinogenesis Technical Report Series No. 57, DHEW Publication No. (NIH) 78–1363. Washington, DC, US Government Printing Office.
Nery, R. (1969): Acylation of cytosine by ethyl N-hydroxycarbamate and its acyl derivatives and the binding of these agents to nucleic acids and proteins. J. Chem. Soc. (C), 1860–1865.
Newberne, P.M. (1979): Nitrite promotes lymphoma incidence in rats. Science 204: 1079–1081.
Oppenheimer, J.H., Surks, M.I., (1975): Biochemical basis of thyroid hormone action. In: G. Litwack (ed.), Biochemical Actions of Hormones. New York: Academic Press, pp. 119–157.
Parrington, J.M., Delhanty, J.D.A., Baden, H.P. (1971): Unscheduled DNA synthesis, UV-induced chromosome aberrations and SV-40 transformation in cultured cells from xeroderma pigmentosum. Ann. Hum. Genet. 35: 149–160.
Pastan, I., Adhya, S. (1976): Cyclic adenosine 5′-monophosphate in Escherichia coli. Bacteriol. Rev. 40: 527–551.
Prejean, J.D., Griswold, A.E., Casey, A.E., Peckham, J.C., Weisburger, J.H., Weisburger, E.K., Wood, H.B., Jr. (1972): Carcinogenicity studies of clinically used anticancer agents. Proc. Am. Assoc. Cancer Res. 13: 112.
Propping, P., Rohrborn, G., Buselmaier, W. (1972): Comparative investigations on the chemical induction of point mutations and dominant lethal mutations in mice. Mol. Gen. Genet. 117: 197–209.
Purchase, I.F.H., Richardson, C., Anderson, D. (1976): Chromosomal and dominant lethal effects of vinyl chloride. Lancet 2: 410–411.
Radomski, J.L. (1961): The absorption, fate and excretion of citrus red no. 2 (2,5-dimethoxyphenyl-azo-2-naphthol) and ext. D and C red no. 14 (l-xylylazo-2-naphthol). J. Pharmacol. Exp. Ther. 134: 100–109.
Reddy, B.S., Narisawa, T., Wright, P., Vukusich, D., Weisburger, J.H., Wynder, E.L. (1975): Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res. 35: 287–290.
Remers, W.A. (1979): The Chemistry of Antitumor Antibiotics, Vol. 1. New York: John Wiley and Sons, pp. 176–220.
Rinkus, S.J., Legator, M.S. (1979): Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system. Cancer Res. 39: 3289–3318.
Rohrborn, G., Hansmann, I. (1974): Oral contraceptives and chromosome segregation in oocytes of mice. Mutat. Res. 26: 535–544.
Rosenkranz, H.S., Speck, W.T. (1975): Mutagenicity of metronidazole: activation by mammalian liver microsomes. Biochem. Biophys. Res. Commun. 66: 520–525.
Russell, W.L. (1975): Results of tests for possible transmitted genetic effects of hycanthone in mammals. J. Toxicol. Environ. Health. 7: 301–304.
Sasaki, M.S., Tonomura, A., Matsubara, S. (1970): Chromosome constitution and its bearing on the chromosomal radiosensitivity in man. Mutat. Res. 70: 617-633.
Sawada, M., Ishidate, M., Jr. (1978): Colchicine-like effect of diethylstilbestrol (DES) on mammalian cells in vitro. Mutat. Res. 57: 175–182.
Schachtschabel, D.O., Zilliken, F., Saito, M., Foley, G.E. (1969): Inhibition of DNA synthesis and chromosome aberrations in cultured Ehrlich ascites tumor cells following treatment with luteoskyrin. Exp. Cell Res. 57: 19–28.
Schellas, H.F. (1974): Malignant potential of the dysgenetic gonad. Obstet. Gynecol. 44: 298–309, 455–462.
Schöneich, J. (1976): Safety evaluation based on microbial assay procedures. Mutat. Res. 47: 89–94.
Schuphan, I., Rosen, J.D., Casida, J.E. (1979): Novel activation mechanism for the promutagenic herbicide diallate. Science 205: 1013–1015.
Selkirk, J. (1977): Divergence of metabolic activation systems for short-term mutagenesis assays. Nature (Lond.) 270: 604–607.
Sentein, P. (1974): Action de la chromomycine A3 sur les chromosomes dans les blastomères en segmentation de l’oeuf de pleurodèle, Comparaison avec d’autres substances chromatoclasiques. C.R. Hebd. Séances Acad. Sei. Ser. D. 278: 295–298.
Shimazu, H., Shiraishi, N., Akematsu, T., Ueda, N., Sugiyama, T. (1976): Carcinogenicity screening tests on induction of chromosomal aberrations in rat bone marrow cells in vivo. Mutat. Res. 38: 341.
Sincock, A.M. (1977): Preliminary studies of the in vitro cellular effects of asbestos and fine glass dusts. In: H.H. Hiatt, J.D. Watson, and J.A. Winsten (eds.), Origins of Human Cancer, Book A, New York: Cold Spring Harbor Laboratory, pp. 941–954.
Stich, H.F., Laishes, B.A. (1975): The response of xeroderma pigmentosum cells and controls to the activated mycotoxins, aflatoxins and sterigmatocystin. Int. J. Cancer 16: 266–274.
Stoltz, D.R., Poirier, L.A., Irving, C.C., Stich, H.F., Weisburger, J.H., Grice, H.C. (1974): Evaluation of short-term tests for carcinogenicity. Toxicol. Appl. Pharmacol. 29: 157-180.
Stoner, G.D., Shimkin, M.B., Kniazeff, A.J., Weisburger, J.H., Weisburger, E.K., Gori, G.B. (1973): Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice. Cancer Res. 33: 3069–3085.
Stoner, G.D., Weisburger, E.K., Shimkin, M.B. (1975): Tumor response in strain A mice exposed to silylating compounds used for gasliquid chromatography. J. Natl Cancer Inst. 54: 495–491.
Taylor, A.M.R. (1978): Unrepaired DNA strand breaks in irradiated ataxia telangiectasia lymphocytes suggested from cytogenetic observations. Mutat. Res. 50: 407–418.
Terzaghi, E., Okada, Y., Streisinger, G., Emrich, J., Inouye, M., Tsugita, A. (1966): Change of a sequence of amino acids in phage t4 lysozyme by acridine-induced mutations. Proc. Natl. Acad. Sci. USA 56: 500–507.
Van Duuren, B.L., Goldschmidt, B.M., Katz, C., Seidman, I. (1972): Dimethylcarbamyl chloride, a multipotential carcinogen. J. Natl. Cancer Inst. 43: 1539–1541.
Vig, B.K., Kontras, S.B., Aubele, A. (1969): Sensitivity of Gj phase of mitotic cell cycle to chromosome aberrations induced by daunomycin. Mutat. Res. 7: 91–97.
Vogel, E. (1977): Identification of carcinogens by mutagen testing in Drosophila: The relative reliability for the kinds of genetic damage measured. In: H.H. Hiatt, J.D. Watson, and J.A. Winsten (eds.), Origins of Human Cancer, Book C. New York: Cold Spring Harbor Laboratory, pp. 1483–1497.
Vogel, E., Sobels, F.H. (1976): The function of Drosophila in genetic toxicology testing. In: A. Hollaender (ed.), Chemical Mutagens: Principles and Methods for Their Detection. New York: Plenum Press, pp. 93–142.
Weber, E., Bidwell, K., Legator, M.S. (1975): An evaluation of the micronucleus test using triethylenemelamine, trimethylphosphate, hycanthone and niridazole. Mutat. Res. 25: 101-106.
Wertelecki, W., Fraumeni, J.F., Jr., Mulvihill, J.J. (1970): Nongonadal neoplasia in Turner’s syndrome. Cancer 26: 485–488.
White, I.N.H., Mattocks, A.R. (1972): Reaction of dihydropyrrolizines with deoxyribonucleic acids in vitro. Biochem. J. 128: 291–297.
Wild, D. (1978): Cytogenetic effects in the mouse of 17 chemical mutagens and carcinogens evaluated by the micronucleus test. Mutat. Res. 56: 319–327.
Williams, D.L., Hagen, A.A. and Runyan, J.W., Jr. (1971): Chromosome alterations produced in germ cells of dogs by progesterone. J. Lab. Clin. Med. 77: 417–429.
Wobus, A.M., Wobus, U., Schoneich, J. (1977): Effects of the antibiotic neotropsin on mouse ascites tumour chromosomes in vitro. Experientia 55: 1212–1213.
Wood, R.C., Ferone, R., Hitchings, G.H. (1961): The relationship of cellular permeability to the degree of inhibition by amethopterin and pyrimethamine in several species of bacteria. Biochem. Pharmacol. 6: 113–124.
Yahagi, T., Nagao, M., Matsushima, T., Seino, Y., Sawamura, N., Shirai, A., Kawachi, T., Sugimura, T. (1978): An improved method for detecting mutagens. Mutat. Res. 55: 285.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag New York Inc.
About this paper
Cite this paper
Legator, M.S., Rinkus, S.J. (1981). Mutagenicity Testing: Problems in Application. In: Stich, H.F., San, R.H.C. (eds) Short-Term Tests for Chemical Carcinogens. Topics in Environmental Physiology and Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5847-6_43
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5847-6_43
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-5849-0
Online ISBN: 978-1-4612-5847-6
eBook Packages: Springer Book Archive